| Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | AU$ 5.44M | AU$ 4.02M | AU$ 3.92M | AU$ 5.12M | AU$ 4.34M |
| Gross Profit | AU$ 5.31M | AU$ 3.80M | AU$ 3.63M | AU$ 4.76M | AU$ 3.98M |
| Operating Income | AU$ -14.57M | AU$ -19.60M | AU$ -14.64M | AU$ -15.50M | AU$ -15.18M |
| EBITDA | AU$ -14.63M | AU$ -19.46M | AU$ -17.51M | AU$ -17.39M | AU$ -19.36M |
| Net Income | AU$ -12.15M | AU$ -19.12M | AU$ -13.81M | AU$ -12.85M | AU$ -15.31M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | AU$ 40.66M | AU$ 12.64M | AU$ 15.77M | AU$ 34.81M | AU$ 28.12M |
| Total Assets | AU$ 46.03M | AU$ 19.22M | AU$ 27.32M | AU$ 41.36M | AU$ 33.59M |
| Total Debt | AU$ 155.46K | AU$ 159.04K | AU$ 210.38K | AU$ 117.49K | AU$ 65.65K |
| Net Debt | AU$ -33.00M | AU$ -12.48M | AU$ -15.56M | AU$ -34.69M | AU$ -28.05M |
| Total Liabilities | AU$ 3.62M | AU$ 5.43M | AU$ 4.50M | AU$ 5.89M | AU$ 3.12M |
| Stockholders' Equity | AU$ 42.40M | AU$ 13.80M | AU$ 22.81M | AU$ 35.47M | AU$ 30.47M |
| Cash Flow | |||||
| Free Cash Flow | AU$ -11.45M | AU$ -12.61M | AU$ -20.04M | AU$ -12.43M | AU$ -17.34M |
| Operating Cash Flow | AU$ -11.45M | AU$ -12.61M | AU$ -20.04M | AU$ -12.34M | AU$ -17.33M |
| Investing Cash Flow | AU$ -7.50M | AU$ -5.72K | AU$ -36.46K | AU$ -89.15K | AU$ -10.47K |
| Financing Cash Flow | AU$ 39.67M | AU$ 9.22M | AU$ 124.34K | AU$ 16.30M | AU$ 36.69M |
Alterity Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.